Colorado will soon ask CMS for permission to use outcomes-based prescription drug contracts in its Medicaid program, a state health official told Inside Health Policy Tuesday (Oct. 16). Oklahoma is the only state that has already obtained permission from CMS to enter into such contracts, and Michigan filed a request last month. In outcomes-based contracts, drug manufacturers could be on the hook for giving the state additional rebates if patients do not meet specific treatment benchmarks. In return, the...